前往化源商城

Drug Discovery Today 2005-05-15

Keynote review: Medicinal chemistry strategies to CB1 cannabinoid receptor antagonists

Jos H.M. Lange, Chris G. Kruse

文献索引:Drug Discov. Today 10 , 693-702, (2005)

全文:HTML全文

摘要

The proven clinical efficacy of the CB1 cannabinoid receptor antagonist rimonabant in obesity and its further therapeutic potential has given a tremendous impetus to the discovery of novel CB1 antagonists.

相关化合物

结构式 名称/CAS号 全部文献
1-(2,4-二氯苯基)-5-(4-甲氧基苯基)-4-甲基-N-(1-哌啶基)-1H-吡唑-3-甲酰胺 结构式 1-(2,4-二氯苯基)-5-(4-甲氧基苯基)-4-甲基-N-(1-哌啶基)-1H-吡唑-3-甲酰胺
CAS:502486-89-7